J Lipid Res 52 , 7886 (2011)
While the increase in risk appears modest, the findings raise important questions about how rapid weight loss and appetite suppression may affect bone health over time
For further information about SureNano Science Ltd., visit the SureNano Science profile
Cells were washed with PBS, and fluorescence measured according to manufacturer instructions using a GloMax Explorer system (Promega)
If you switch during your trial, youll begin a new trial for the Noom Med Program you switch to
Researchers from the University of Oxford, led by postdoctoral researcher Sam West, examined 37 clinical studies published up to February 2025, involving more than 9,000 participants who had taken obesity medications, including GLP-1 receptor agonists, for an average of 39 weeks